| | 
Part, Chapter, Paragraph
1 II, 5. 5. 3| diagnostic validity for definite MS of 94%. It links with
2 II, 5. 5. 3| two large categories for definite and probable MS, and relevant
3 II, 5. 5. 3| subcategories: clinically definite MS (CDMS), laboratory-supported
4 II, 5. 5. 3| CDMS), laboratory-supported definite MS (LSDMS), clinically probable
5 II, 5. 5. 3| Daily Living~CDMS~Clinically Definite Multiple Sclerosis~CPMS~
6 II, 5. 5. 3| LSDMS~Laboratory-Supported Definite Multiple Sclerosis~LSPMS~
7 IV, 11. 5. 7| the supply appears to be definite, mechanisms that reduce
|
|
| |